Regulus Therapeutics Inc. (RGLS) Net Cash Provided by (Used in) Financing Activities USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Regulus Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2024.
  • Regulus Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $93.1 M.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.8 M, a 163% increase from 2022.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.49 M, a 91.6% decline from 2021.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $53.7 M, a 465% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $93.1 M +$93.9 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$805 K -$807 K -40350% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $2 K* -$6.33 M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $6.34 M +$6.4 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 -$67 K -$724 K -110% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $657 K -$44 K -6.28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $701 K +$433 K +162% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $268 K -$260 K -49.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $528 K -$387 K -42.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $915 K -$9.27 M -91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q1 2014 $10.2 M +$10 M +5785% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-09
Q1 2013 $173 K +$247 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 -$74 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.